The relationship between lower sodium intake and total mortality remains controversial.
N umerous randomized trials and observational studies have demonstrated a direct relationship between dietary sodium intake and blood pressure (1, 2) . Although the effect is strongest among those with hypertension (3), there is also a smaller but consistent effect of lowering sodium on blood pressure among those with high normal or prehypertensive blood pressure levels. The DASHSodium (Dietary Approaches to Stop Hypertension) trial, a dose-response trial with 3 levels of sodium intake, found a significant direct relationship between sodium intake and blood pressure levels that was evident among subjects both with and without hypertension (4). A recent Cochrane meta-analysis of data from 35 trials (1) found that a 100 mmol reduction in 24-h urinary sodium led to a reduction in sys- How well this blood pressure reduction translates into a beneficial effect on incidence of cardiovascular disease (CVD) and particularly on total mortality remains controversial. A report from the Institute of Medicine in 2013 (5) found that there was a link between excessive sodium intake and risk of CVD, particularly for stroke. However, that report also found that the evidence for the effects of sodium intake below 2,300 mg/24 h was inconsistent and inconclusive. Few studies have available data in this range of sodium, and several that did report outcomes associated with these levels suffered from limitations due to reverse causation, possible confounding, and measurement error (6) .
Since that report, additional observational studies (7, 8) and a meta-analysis (9) have reported an increase in cardiovascular disease and mortality among those at the lowest levels of sodium intake, suggesting a U-shaped relationship between sodium and health outcomes. In contrast, data from 10 to 15 years of post-trial follow-up in TOHP (Trials of Hypertension Prevention) participants identified a direct linear relationship between average sodium excretion and CVD down to the lowest levels of intake (10) . Unlike other reports, this last study used a gold-standard assessment of sodium intake based on the mean of several 24-h sodium excretions accrued over 1.5 to 4 years of exposure ascertainment. In the current paper, we report the relationship between sodium intake and total mortality during more extended follow-up through 2013, for a total of 23 to 26 years.
We include results from analyses based on both the exploration of later effects of the randomized sodium reduction interventions in the TOHP trials and the observational relationship between average 24-h sodium excretion in those who were not randomized to an active sodium intervention. We also estimated cumulative HRs over time in 5-year periods and before and after 10 years of follow-up.
METHODS
In observational analyses of usual intake, sodium excretion levels from 3 to 7 collections of 24-h urine specimens obtained during the course of the trial periods were averaged. Participants not in an active sodium intervention who remained alive and CVDfree at the end of the trial periods were included in these analyses. Absolute levels of 24-h urinary sodium excretion were grouped into categories of <2,300, 2,300 to <3,600, 3,600 to <4,800, and 4,800 mg or higher. Baseline characteristics by sex were expressed as percentages or means and were tested for trend over sodium categories using chisquare statistics or regression analysis.
Cox regression analysis was used to estimate the association between mortality and the absolute sodium level in a continuous fashion and after data were grouped into the previously mentioned categories. Models were adjusted for clinic, age, sex, race/ ethnicity, and other treatment assignments (model 1) and additionally for education, baseline weight, alcohol use and amount, smoking, exercise, potassium excretion, and family history of CVD (model 2).
Interactions among time, sex, age, race, and weight loss intervention in TOHP II were examined. Penalized splines with 4 degrees of freedom were used to examine linearity of effect. All analyses were conducted using SAS version 9.2 software (SAS, Cary, North Carolina), except for the cumulative incidence plots and spline analyses, which were conducted using R software (R Foundation for Statistical
Computing, Vienna, Austria), using the "coxph"
function.
RESULTS

ANALYSIS BASED ON RANDOMIZED ASSIGNMENT.
Detailed comparisons of the randomized groups have been reported (11) . Among the 744 participants in TOHP I who were randomized to the sodium reduction intervention or control, the average age was 43 years old, 71% were male, and 20% were African Sodium and All-Cause Mortality rates were slightly lower in the intervention groups ( Cumulative mortality curves showed a consistently lower incidence among those in the active group Baseline characteristics by average level of urinary sodium and sex during the trials are presented in Table 2 . Many of those at a higher level of urinary sodium excretion were participants in phase II of Table 1 ). Na ¼ sodium; TOHP ¼ Trials of Hypertension Prevention. Studies using questionnaires to assess sodium intake (8) are thus using an instrument that may be biased due to both random and systematic errors. In addition, while 24-h diet recalls or food records can assess intake at the population or group level, these are inadequate to assess individual consumption because of large day-to-day variation in diet (16) .
Many studies that have examined the health effects of dietary sodium are based on urinary sodium excretion data. In these studies, quality of the exposure assessment has varied substantially. Overnight or spot urine samples may not adequately reflect intake compared to "gold-standard" 24-h urine specimens (17, 18) . Several studies that have found a U-or J-shaped relationship between sodium intake and CVD or mortality have used overnight or urinary spot samples to estimate dietary sodium intake (7, 19, 20) , but these estimates could be affected by error in estimation of dietary sodium. Even a single 24-h urine specimen may not be sufficient to accurately estimate usual sodium consumption. In a simulated space flight, urinary sodium excretion demonstrated considerable variability despite a constant sodium intake (21, 22) . Researchers estimated that 3 24-h collections would improve accuracy to 75% compared to sodium ingestion and that 7 would be needed to improve accuracy to 92% (23) . The TOHP study reported here used up to 7 excretion measurements and used the most accurate sodium exposure assessment in relationship to outcomes to date.
Another issue that may lead to bias in effect estimates is the possibility of reverse causation. Some studies include participants with prior cardiovascular (7, 19) or other diseases, including diabetes (24, 25) .
These individuals may have been advised to limit their sodium intake or have reduced caloric intake Spline plot of average sodium intake based on multiple 24-h excretions and total mortality in observational analysis of usual intake in the TOHP cohorts. HRs are shown for total mortality over >20 years as a function of usual sodium intake averaged over 3 to 7 urine collections over 1 to 3 years at baseline. Mortality is lowest among those with usual sodium intake <2,300 mg/24 h and highest among those with levels >6,000 mg/24 h. There is a significant direct linear effect of sodium on mortality Finally, it is possible that some of the effect of our estimate of usual sodium intake may be related to other dietary factors, such as more fruit and vegetable intake and less consumption of saturated fat. Although some dietary information was available in TOHP I, this was collected in only a small subset in TOHP II. We were thus unable to control for such factors in our analyses with sufficient power. All of our analyses, however, controlled for the weight loss intervention in TOHP II as well as for baseline weight, which should be correlated with energy intake. Potassium excretion may be another marker for a more healthy dietary pattern and was included in our adjusted models.
CONCLUSIONS
In contrast to some other studies, we found a direct linear relationship of an accurate measure of usual sodium intake to total mortality over a period of 23 to 26 years, with higher risk at high sodium intake and no evidence of a U or J shape, although as in other studies, power is limited to estimate effects at the tails of the sodium distribution. The relationship was slightly stronger for the sodium/potassium ratio, 2
electrolytes that are suspected of playing joint roles in the pathogenesis of hypertension (27) . Our analysis of the randomized sodium interventions was also consistent with an effect on mortality, with an estimated 15% reduced risk, albeit nonsignificant, among those randomly assigned to the active sodium reduction intervention versus those in usual care.
Average levels of sodium intake in the United
States remain too high (28) and even appear to be increasing (29) . In 2010, the Institute of Medicine recommended a gradual reduction in sodium levels (30), which would be more palatable to consumers. 
PERSPECTIVES COMPETENCY IN MEDICAL KNOWLEDGE:
Studies that used accurate measurements have found lower sodium intake beneficial.
TRANSLATIONAL OUTLOOK: New strategies are needed to reduce the amount of sodium in the food supply and to educate people about the importance of dietary sodium restriction.
